Parametric Portfolio Associates’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Parametric Portfolio Associates’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$174K	Buy	105,446 +38,818	+58%	+$69.3K	﹤0.01%	3471
2021 Q4	$159K	Sell	66,628 -21,171	-24%	-$86.2K	﹤0.01%	3465
2021 Q3	$479K	Sell	87,799 -18,111	-17%	-$112K	﹤0.01%	3126
2021 Q2	$788K	Buy	+105,910	New	+$751K	﹤0.01%	2875
2021 Q1	–	Sell	-10,419	Closed	-$95K	–	4103
2020 Q4	$95K	Buy	+10,419	New	+$85.5K	﹤0.01%	3890
2020 Q3	–	Sell	-21,315	Closed	-$158K	–	3999
2020 Q2	$158K	Buy	21,315 +9,394	+79%	+$63K	﹤0.01%	3690
2020 Q1	$73K	Buy	+11,921	New	+$77.8K	﹤0.01%	3783

Other funds holding KLDO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's KLDO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Kaleido Biosciences, Inc. Common Stock (KLDO) stake by 58% in Q1 2022, buying an estimated $69.3K and bringing the position to 105,446 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Parametric Portfolio Associates first reported a position in KLDO in Q1 2020 and has held it in 7 quarters since. The position peaked at $788K in Q2 2021. 63 funds tracked by Wall St. Rank hold KLDO as of Q1 2022.

Parametric Portfolio Associates held 105,446 shares of Kaleido Biosciences, Inc. Common Stock worth $174K as of Q1 2022.
Parametric Portfolio Associates bought 38,818 Kaleido Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $69.3K.
Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3471 holding.
Parametric Portfolio Associates first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2020 and has held it in 7 quarters since.
Parametric Portfolio Associates's Kaleido Biosciences, Inc. Common Stock position peaked at $788K in Q2 2021.
63 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.